Gene Query: MSRB2

Dataset Description Geneva Score
RNA-seq analysis of uveal melanoma cells treated with FR900359 47.79
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 40.59
RNA-seq analysis of BAP1-depleted uveal melanoma cells 22.16
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 21.21
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 19.86
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 19.32
HNF1A deficiency impairs β-cell fate, granule maturation and function 14.06
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 13.52
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 13.07
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 12.29
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 12.06
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 11.85
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 11.36
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 10.73
Generating Patterned Kidney Organoids for Studying Development and Diseases 10.61
Genome wide expression change by RNF168 knocking down in MCF-7 cells 10.2
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 10.2
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 9.52
Transcriptome-wide identification of CELF2 functional targets in T cells 9.42
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 9.31
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 9.02
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 8.7
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 8.7
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 8.58
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 8.36
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 8.31
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 8.24
Single-Cell Genotyping of Transcriptomes 7.83
RNA-seq of Single-Cell Genotyping of Transcriptomes 7.83
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 7.8
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 7.11
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 7.04
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 7.03
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 6.86
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 6.74
Transcriptome analysis of kidney organoids 6.74
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 6.56
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 6.42
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 6.32
The role of FAM46C in myeloma cells 6.31
The role of FAM46C in myeloma cells [sequencing] 6.31
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 6.16
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.97
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 5.89
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 5.87
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.81
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 5.8
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 5.8
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 5.75
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 5.68
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 5.66
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 5.61
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 5.58
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 5.5
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 5.45
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 5.3
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 5.3
MARS Seq data from human cortical organoids 5.25
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 5.19
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.18
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 5.05
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 4.88
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 4.73
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 4.63
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 4.6
Global expression profiles in cardiac progenitor cells generated by ISX-9 4.55
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 4.55
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 4.5
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 4.48
Differentially expressed genes post knock down of lincDUSP26 4.43
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.36
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 4.31
Single-cell analysis of adult human ovary using 10X genomics 4.26
The regulartory role of ZCCHC24 in splicing machinery 4.23
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 4.12
Identification of renal resident macrophages across species 4.11
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 4.08
The transcriptome effect of overexpressing EZH2 in MCF7 4.06
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 4.01
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 4.0
BAF controls genome accessibility 3.95
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 3.95
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 3.93
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 3.92
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 3.88
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 3.84
Transcriptional profiling of microglia; current state of the art and future perspectives 3.8
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 3.76
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 3.76
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 3.69
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 3.64
HNRNPM-regulated splicing dependencies in prostate cancer 3.64
FOXP2's impact on the primate transcriptome 3.62
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 3.57
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 3.57
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.55
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.55
CDK4/6 inhibitor resistance in prostate cancer 3.52
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.51
LNCaP treated with iBET 3.46
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 3.43
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 3.43
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 3.41
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 3.35
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 3.28
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 3.24
Global analysis of enhancer targets: Mosaic-seq 3.23
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.23
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 3.19
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 3.17
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 3.15
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 3.14
Active translatome profiling with RiboLace in MCF7 cells 3.13
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 3.11
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 3.11
miRNAs affected by antagomiR-17 treatment 3.1
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 3.07
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 3.06
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 3.05
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 3.05
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 3.05
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 3.04
O-glcnAc reprograms cellular energetics 3.02
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 2.97
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 2.97
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.83
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 2.82
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 2.81
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 2.81
Genome wide expression change in LCC2 and MCF-7 cells 2.75
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 2.68
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 2.67
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 2.66
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 2.66
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 2.61
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 2.61
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 2.61
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 2.59
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 2.59
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 2.58
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 2.55
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 2.55
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 2.54
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 2.52
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 2.51
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 2.5
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 2.49
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.49
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.47
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 2.46
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.46
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.43
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.43
m6A-dependent regulation of messenger RNA stability 2.42
EWSR1 influences alternative splicing through direct and indirect mechanisms 2.41
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.4
NR2F2 study 2.4
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 2.4
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 2.4
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 2.38
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 2.37
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 2.36
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.35
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.33
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 2.32
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 2.32
The landscape of alternative splicing in aggressive prostate cancers 2.31
scRNASeq analysis of cycling cardiomyocytes 2.26
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 2.25
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 2.23
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 2.23
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 2.23
TT-Seq captures the human transient transcriptome 2.22
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 2.22
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 2.21
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.21
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 2.21
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.19
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 2.18
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 2.15
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.15
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 2.14
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 2.12
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 2.11
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 2.1
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 2.09
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.08
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.08
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.06
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.06
The comparison of high-throughput single-cell RNA-seq methods 2.06
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.05
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 2.05
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.03
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 2.03
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 2.02
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 2.01
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 2.01
Single-nucleotide-resolution mapping of HBV promoters using CAGE 2.0
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 1.98
Repurposing of promoters and enhancers during mammalian evolution 1.98
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.97
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 1.97
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 1.97
Single cell transcriptome of peritoneal cells 1.95
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 1.95
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 1.94
CROP-Seq in Primary Human T Cells 1.94
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 1.92
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 1.91
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 1.91
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 1.91
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 1.9
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.9
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 1.89
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 1.89
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 1.88
Effect of CHKA knockdown on C4-2 cell transcriptome 1.87
Gene expression changes in human melanoma cell lines compared to primary melanocytes 1.86
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 1.86
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.86
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.85
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 1.84
Chromatin landscape of human visceral and subcutaneous adipocytes 1.83
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 1.82
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.81
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.81
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 1.76
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 1.75
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.75
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 1.74
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 1.74
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.72
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.72
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.71
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 1.7
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 1.69
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.69
Paxillin regulates genomic networks in prostate cancer [C4-2] 1.68
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 1.68
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.67
Single-cell analysis of human kidney organoids 1.67
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.65
The Human Testis Cell Atlas via Single-cell RNA-seq 1.65
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 1.65
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.64
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 1.63
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 1.62
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 1.62
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 1.62
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 1.61
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 1.61
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 1.61
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 1.61
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 1.6
A single-cell transcriptome atlas of the human pancreas 1.57
Evaluating pre-clinical models for studying NASH driven HCC. 1.57
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 1.57
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 1.57
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 1.57
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.56
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.56
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 1.55
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 1.55
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 1.54
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 1.54
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 1.54
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 1.54
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 1.53
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 1.5
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 1.49
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.49
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.47
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.47
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.47
RNA-seq analysis of breast cancer 1.46
RNA-seq analysis and shRNA screen of breast cancer 1.46
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.44
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.43
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.42
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 1.42
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 1.4
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 1.4
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 1.4
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 1.39
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 1.38
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 1.38
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 1.38
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 1.38
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 1.36
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 1.36
The effect of insulin on mRNA transcription of human pluripotent stem cells 1.35
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 1.33
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 1.32
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 1.32
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 1.3
Dynamic reorganization of nuclear architecture during human cardiogenesis 1.3
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 1.29
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 1.29
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 1.29
Generation and persistence of human tissue-resident memory T cells in lung transplantation 1.28
Energy Metabolism during Anchorage-Independence 1.28
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.27
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.26
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 1.25
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 1.25
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 1.25
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.24
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 1.23
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 1.23
RNA seq analysis of human Fetal and adult derived Enterospheres 1.23
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.23
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.22
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 1.21
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.2
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.17
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 1.16
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 1.16
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 1.15
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.14
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 1.13
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 1.13
PGE2 mediated gene expression changes in human cervical stromal cells 1.12
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 1.11
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.11
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 1.11
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 1.1
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 1.09
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.08
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.08
Cleavage Factor Im as a key regulator of 3’ UTR length 1.05
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 1.05
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 1.05
RNAseq of cell lines with knocked in ESR1 mutations 1.03
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 1.02
Human Treg IL-12 stimulation 1.01
RNA-sequencing of healthy human skeletal myocytes 1.0
RNA-Seq in neutrophils from Antiphospholipid Syndrome 1.0
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.99
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.99
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.98
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 0.97
U2AF1 mutations alter splice site recognition in hematological malignancies 0.96
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 0.96
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 0.96
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 0.94
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.93
Dilated cardiomyopathy vs Myocarditis 0.92
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.91
MRTF activates TEAD-YAP target gene expression 0.9
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 0.89
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 0.89
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 0.89
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.88
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 0.87
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.86
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.86
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.86
RNA-seq differential expression studies: more sequence, or more replication? 0.86
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.86
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.86
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 0.86
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 0.85
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.85
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.84
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.83
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.82
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.78
Tpl-2 and MEK small molecule inhibitors 0.78
Tpl-2 small molecule project 0.78
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.77
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 0.74
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.73
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.73
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.73
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.73
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.73
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.72
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.7
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.69
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.69
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.68
RNA-Seq and expression data from human adipose tissue 0.67
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.67
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.67
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.66
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.66
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.65
Studying the selectivity of a small molecule Synucleozid on transcriptome 0.65
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.65
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.64
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.63
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 0.62
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.62
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.61
Dysregulated immune system networks in war veterans with PTSD 0.61
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.59
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 0.58
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.58
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 0.58
A single cell reference map for human blood and tissue T cell activation 0.57
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.57
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.56
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 0.55
quanTIseq: quantifying immune contexture of human tumors 0.55
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.55
Ribosome profiling upon inhibition of eIF4A 0.55
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 0.54
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.54
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.54
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.53
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.53
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 0.52
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 0.52
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.52
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.52
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.52
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.51
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.51
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 0.51
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.49
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 0.48
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.47
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.47
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 0.45
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.44
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.44
An integrative analysis of non-coding regulatory DNA variations associated with autism 0.44
MCF-7 as a model for functional analysis of breast cancer risk variants 0.43
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 0.42
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 0.42
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 0.41
Hepatocyte maturation 0.4
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 0.37
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.37
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 0.35
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 0.35
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.34
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.34
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 0.34
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.33
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.32
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.32
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.32
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.32
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 0.31
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 0.31
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.31
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.3
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.3
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.3
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.29
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.28
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.28
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.28
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.26
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 0.26
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 0.26
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.26
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.24
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.24
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.22
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 0.21
The circadian transcriptional landscape in primary human mammary epithelial cells 0.18
Expression analysis of the TAF1 syndrome 0.17
Hepatic transcriptome of pediatric hepatoblastoma. 0.17
Metabolism as an early predictor of DPSCs aging 0.16
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.16
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.16
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.16
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 0.16
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.15
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.15
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.14
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.14
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.14
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.14
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.14
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 0.13
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.11
Downregulation of DDX5/DDX17 and REST 0.09
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.09
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.08
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.08
SF3B1 Degron knockdown RNA-seq 0.08
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.07
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.07
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.06
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.06
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.05
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.05
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 0.04
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.03
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.03
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.03
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.03
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.02
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.02
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.01
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation